Dogwood Therapeutics logo

Dogwood Therapeutics

DWTX | NASDAQ
Chart Builder DCF Calculator
$1.06
-$0.05 (-4.50%)
At close: Nov 16, 2026, 4:00 PM ET
$1.11
+$0.05 (+4.72%)
After-hours: Nov 16, 2026, 7:36 PM ET
-4.50%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
40.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #516/1021 (Top 51%)

Key Statistics

Market Data

Market Cap $40.52M
1D Range
1.00 1.16
52W Range
1.00 6.82

Valuation (TTM)

PE -1.19
PB 0.00
EV/EBITDA -2.04

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $12.00
Loading financial charts...

Profile

Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions ...

Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Dec 17, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.14
Beat +9.68%
REV
$100K
Beat 0.00%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$12.00
Upside
+1032.08%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.